McCarthy GM - Search Results

1

Performance characteristics and predictors of temporal artery ultrasound for the diagnosis of giant cell arteritis in routine clinical practice in a prospective cohort.

Conway R, O'Neill L, McCarthy GM, Murphy CC, Veale DJ, Fearon U, Killeen RP, Heffernan EJ, Molloy ES. Conway R, et al. Among authors: mccarthy gm. Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):72-78. Epub 2019 Jan 4. Clin Exp Rheumatol. 2019. PMID: 30620296 Free article.

2

Ustekinumab for the treatment of refractory giant cell arteritis.

Conway R, O'Neill L, O'Flynn E, Gallagher P, McCarthy GM, Murphy CC, Veale DJ, Fearon U, Molloy ES. Conway R, et al. Among authors: mccarthy gm. Ann Rheum Dis. 2016 Aug;75(8):1578-9. doi: 10.1136/annrheumdis-2016-209351. Epub 2016 May 3. Ann Rheum Dis. 2016. PMID: 27143653 No abstract available.

3

Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial.

Conway R, O'Neill L, Gallagher P, McCarthy GM, Murphy CC, Veale DJ, Fearon U, Molloy ES. Conway R, et al. Among authors: mccarthy gm. Semin Arthritis Rheum. 2018 Dec;48(3):523-528. doi: 10.1016/j.semarthrit.2018.04.004. Epub 2018 Apr 22. Semin Arthritis Rheum. 2018. PMID: 29776658

4

Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis.

Conway R, O'Neill L, McCarthy GM, Murphy CC, Fabre A, Kennedy S, Veale DJ, Wade SM, Fearon U, Molloy ES. Conway R, et al. Among authors: mccarthy gm. Ann Rheum Dis. 2018 Dec;77(12):1815-1824. doi: 10.1136/annrheumdis-2018-213488. Epub 2018 Aug 10. Ann Rheum Dis. 2018. PMID: 30097452

5

Interleukin-6 does not upregulate pro-inflammatory cytokine expression in an ex vivo model of giant cell arteritis.

O'Neill L, McCormick J, Gao W, Veale DJ, McCarthy GM, Murphy CC, Fearon U, Molloy ES. O'Neill L, et al. Among authors: mccarthy gm. Rheumatol Adv Pract. 2019 May 6;3(1):rkz011. doi: 10.1093/rap/rkz011. eCollection 2019. Rheumatol Adv Pract. 2019. PMID: 31431999 Free PMC article.

6

Eicosanoids, osteoarthritis, and crystal deposition diseases.

Molloy ES, McCarthy GM. Molloy ES, et al. Among authors: mccarthy gm. Curr Opin Rheumatol. 2005 May;17(3):346-50. doi: 10.1097/01.bor.0000155363.61120.c3. Curr Opin Rheumatol. 2005. PMID: 15838249 Review.

7

Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.

McCarthy EM, MacMullan PA, Al-Mudhaffer S, Madigan A, Donnelly S, McCarthy CJ, Molloy ES, Kenny D, McCarthy GM. McCarthy EM, et al. Among authors: mccarthy gm, mccarthy cj. J Rheumatol. 2014 May;41(5):931-7. doi: 10.3899/jrheum.131055. Epub 2014 Apr 1. J Rheumatol. 2014. PMID: 24692520

8

Calcium-Containing Crystals and Osteoarthritis: an Unhealthy Alliance.

Conway R, McCarthy GM. Conway R, et al. Among authors: mccarthy gm. Curr Rheumatol Rep. 2018 Mar 8;20(3):13. doi: 10.1007/s11926-018-0721-9. Curr Rheumatol Rep. 2018. PMID: 29516278 Review.

9

Hydroxyapatite deposition disease of the joint.

Molloy ES, McCarthy GM. Molloy ES, et al. Among authors: mccarthy gm. Curr Rheumatol Rep. 2003 Jun;5(3):215-21. doi: 10.1007/s11926-003-0070-0. Curr Rheumatol Rep. 2003. PMID: 12744814 Review.

10

How crystals damage tissue.

Molloy ES, McCarthy GM. Molloy ES, et al. Among authors: mccarthy gm. Curr Rheumatol Rep. 2004 Jun;6(3):228-34. doi: 10.1007/s11926-004-0073-5. Curr Rheumatol Rep. 2004. PMID: 15134603 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page